Dr Harry Crane
Gastroenterologist and Hepatologist
MBBS, FRACP
Staff Specialist at Department of Gastroenterology and Liver
Research and Clinical Expertise:
Metabolic syndrome, metabolic dysfunction–associated fatty liver disease (MAFLD), viral hepatitis, diagnosis and management of chronic liver disease, liver cancer
Profile
Dr Harry Crane is a specialist gastroenterologist and hepatologist. He obtained his medical degree from the University of Sydney in 2014 and completed advanced training in gastroenterology at St Vincent’s and Liverpool Hospitals. He is a Fellow of the Royal Australian College of Physicians (FRACP).
Dr Crane has worked as a consultant gastroenterologist across several tertiary referral hospitals in Sydney and is currently a Staff Specialist at Liverpool Hospital. He has a broad clinical practice encompassing all aspects of gastroenterology and hepatology.
At Liverpool Hospital, Dr Crane runs a specialist clinic focused on the management of chronic liver disease, including hepatocellular carcinoma (liver cancer). He also manages a wide range of general gastroenterological conditions and performs diagnostic and therapeutic endoscopic procedures.
Dr Crane holds Australian Conjoint Committee accreditation in gastroscopy and colonoscopy and participates in the National Colonoscopy Re-certification Program.
Education
Bachelor of Commerce and Bachelor of Science
University of Sydney (2010)
Bachelor of Medicine and Bachelor of Surgery (MBBS)
University of Sydney (2014)
Fellow of the Royal Australasian College of Physicians (FRACP)
PhD Candidate
Select Publications
Crane H, Danta M. Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)-will there ever be enough data? Annals of Translational Medicine. 2023;11:293-.
Crane H, Eslick GD, Gofton C, Shaikh A, Cholankeril G, Cheah M, Zhong J-H, Svegliati-Baroni G, Vitale A, Kim BK. Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis. Clinical and Molecular Hepatology. 2024;30:436.
Cheah MC, Crane H, George J. Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysis. Hepatology International. 2025:1-12.
Crane H, Gofton C, Sharma A, George J. MAFLD: an optimal framework for understanding liver cancer phenotypes. Journal of Gastroenterology. 2023.
Crane H. Metabolic dysfunction-associated fatty liver disease: the crucial link to CVD. Medicine Today. 2024:10.
Kayes T, Crane H, Symonds A, Dumond J, Cottrell M, Di Girolamo J, Manandhar S, Lim TH, Gane E, Kashuba A, Levy MT. Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection. Alimentary Pharmacology & Therapeutics. 2022;56:510-8.
Svistounov D, Warren A, McNerney GP, Owen DM, Zencak D, Zykova SN, Crane H, Huser T, Quinn RJ, Smedsrød B, Le Couteur DG, Cogger VC. The Relationship between Fenestrations, Sieve Plates and Rafts in Liver Sinusoidal Endothelial Cells. PLoS ONE. 2012;7:e46134.
Crane H, Wu N, Chan P, Nguyen P, Williams AJ, Ng W, Connor SJ. Safety, satisfaction and cost savings of accelerated infusions of standard and intensifiedâdose infliximab for inflammatory bowel disease. Internal Medicine Journal. 2022;52:2143-9.
If you have any enquiries or would like to make an appointment, please email:
Gastroenterology and Liver
Clinic E (123), Level 1
Liverpool Hospital
Corner of Elizabeth and Goulburn Streets
LIVERPOOL NSW 2170
02 8738 4085
FAX: 02 8738 7960
Our phones cannot always be answered, so the best way to contact us is via email or fax
8.30am - 4.00pm
Monday to Friday
